Venture Capital

Sanofi Strengthens Venture Capital Budget

As well as serving as a financial partner to fledgling companies, the VC fund supports future efforts for business development and M&A opportunities within its own operations, Sanofi said. The fresh capital injection will also fuel the expansion and investment capacity of its own investment team on a global scale.

Germany’s Merck Ramps up Venture Capital

Germany’s Merck is allocating an additional €600 million to its strategic corporate venture capital arm M Ventures. The chemicals, pharmaceuticals and life sciences group said the funds will be deployed over the next five years.

BASF invests $4 million in AgVentures II Fund

UK Leads European Biotech Funding

Pfizer and TVM Life Science Ventures Invest in Ixchelsis

Germany’s Merck Expands Venture Capital Fund

J&J and GSK Join Medicxi Ventures

Bio-Based Economy in Europe: Potential Benefits and Risks

UK Life Science Funding Hits 10-Year High

Standing Out in Global Pharmaceutical Contract Manufacturing Market

Venture Firms See Signs of Rebirth in Life Sciences